Column Capital Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | $98.5K | Hold |
1,422
| – | – | 0.01% | 220 |
|
2023
Q2 | $134K | Hold |
1,422
| – | – | 0.02% | 184 |
|
2023
Q1 | $118K | Hold |
1,422
| – | – | 0.02% | 198 |
|
2022
Q4 | $106K | Sell |
1,422
-999
| -41% | -$74.5K | 0.02% | 197 |
|
2022
Q3 | $200K | Hold |
2,421
| – | – | 0.04% | 119 |
|
2022
Q2 | $230K | Hold |
2,421
| – | – | 0.04% | 102 |
|
2022
Q1 | $285K | Buy |
2,421
+200
| +9% | +$23.5K | 0.05% | 102 |
|
2021
Q4 | $288K | Sell |
2,221
-77
| -3% | -$9.99K | 0.06% | 99 |
|
2021
Q3 | $260K | Sell |
2,298
-65
| -3% | -$7.35K | 0.05% | 103 |
|
2021
Q2 | $245K | Sell |
2,363
-53
| -2% | -$5.5K | 0.05% | 108 |
|
2021
Q1 | $202K | Sell |
2,416
-258
| -10% | -$21.6K | 0.05% | 117 |
|
2020
Q4 | $244K | Sell |
2,674
-50
| -2% | -$4.56K | 0.06% | 93 |
|
2020
Q3 | $217K | Sell |
2,724
-33
| -1% | -$2.63K | 0.07% | 85 |
|
2020
Q2 | $190K | Buy |
2,757
+33
| +1% | +$2.27K | 0.06% | 93 |
|
2020
Q1 | $171K | Sell |
2,724
-1,335
| -33% | -$83.8K | 0.07% | 81 |
|
2019
Q4 | $315K | Buy |
+4,059
| New | +$315K | 0.16% | 61 |
|